Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This study aims to demonstrate the noninferiority of DWP14012 to Lansoprazole 15 mg in the
maintenance effect of treatment and confirm the safety of DWP14012 in patients with healed
erosive esophagitis confirmed on EGD after medication treatment.